WNT5A, β‑catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction

Mol Med Rep. 2023 Feb;27(2):28. doi: 10.3892/mmr.2022.12914. Epub 2022 Dec 16.

Abstract

Placental insufficiency is a common cause of intrauterine growth restriction (IUGR). It affects ~10% of pregnancies and increases fetal and neonatal morbidity and mortality. Although Wnt and Hh pathways are crucial for embryonic development and placentation, their role in the pathology of IUGR is still not sufficiently explored. The present study analyzed the expression of positive regulators of the Wnt pathway, WNT5A and β‑catenin, and the expression of the Hh pathway negative regulator suppressor of fused (SUFU). Immunohistochemical and reverse transcription‑quantitative PCR (RT‑qPCR) assays were performed on 34 IUGR and 18 placental tissue samples from physiologic singleton‑term pregnancies. Epigenetic mechanisms of SUFU gene regulation were also investigated by methylation‑specific PCR analysis of its promoter and RT‑qPCR analysis of miR‑214‑3p and miR‑378a‑5p expression. WNT5A protein expression was higher in endothelial cells of placental villi from IUGR compared with control tissues. That was also the case for β‑catenin protein expression in trophoblasts and endothelial cells and SUFU protein expression in trophoblasts from IUGR placentas. The SUFU gene promoter remained unmethylated in all tissue samples, while miR‑214‑3p and miR‑378a‑5p were downregulated in IUGR. The present results suggested altered Wnt and Hh signaling in IUGR. DNA methylation did not appear to be a mechanism of SUFU regulation in the pathogenesis of IUGR, but its expression could be regulated by miRNA targeting.

Keywords: DNA methylation; Hh signaling pathway; WNT5A; Wnt signaling pathway; intrauterine growth restriction; microRNA 214; microRNA 378; placenta; suppressor of fused; β‑catenin.

MeSH terms

  • Endothelial Cells / metabolism
  • Female
  • Fetal Growth Retardation* / genetics
  • Fetal Growth Retardation* / pathology
  • Humans
  • Infant, Newborn
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Placenta / metabolism
  • Placenta / pathology
  • Pregnancy
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Wnt-5a Protein* / genetics
  • Wnt-5a Protein* / metabolism
  • beta Catenin* / genetics
  • beta Catenin* / metabolism

Substances

  • beta Catenin
  • CTNNB1 protein, human
  • MicroRNAs
  • MIRN214 microRNA, human
  • Repressor Proteins
  • SUFU protein, human
  • Wnt-5a Protein
  • WNT5A protein, human
  • MIRN378 microRNA, human

Grants and funding

This research was co-financed by the European Union through the Europe Regional Development Fund, Operational Programme Competitiveness and Cohesion, under grant agreement no. KK.01.1.1.01.0008, Reproductive and Regenerative Medicine-Exploring New Platforms and Potentials.